Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Repair after nephron ablation reveals limitations of neonatal neonephrogenesis
Florian Tögel, M. Todd Valerius, Benjamin S. Freedman, Rossella Iatrino, Mor Grinstein, Joseph V. Bonventre
Florian Tögel, M. Todd Valerius, Benjamin S. Freedman, Rossella Iatrino, Mor Grinstein, Joseph V. Bonventre
View: Text | PDF
Research Article Development Nephrology

Repair after nephron ablation reveals limitations of neonatal neonephrogenesis

  • Text
  • PDF
Abstract

The neonatal mouse kidney retains nephron progenitor cells in a nephrogenic zone for 3 days after birth. We evaluated whether de novo nephrogenesis can be induced postnatally beyond 3 days. Given the long-term implications of nephron number for kidney health, it would be useful to enhance nephrogenesis in the neonate. We induced nephron reduction by cryoinjury with or without contralateral nephrectomy during the neonatal period or after 1 week of age. There was no detectable compensatory de novo nephrogenesis, as determined by glomerular counting and lineage tracing. Contralateral nephrectomy resulted in additional adaptive healing, with little or no fibrosis, but did not also stimulate de novo nephrogenesis. In contrast, injury initiated at 1 week of age led to healing with fibrosis. Thus, despite the presence of progenitor cells and ongoing nephron maturation in the newborn mouse kidney, de novo nephrogenesis is not inducible by acute nephron reduction. This indicates that additional nephron progenitors cannot be recruited after birth despite partial renal ablation providing a reparative stimulus and suggests that nephron number in the mouse is predetermined at birth.

Authors

Florian Tögel, M. Todd Valerius, Benjamin S. Freedman, Rossella Iatrino, Mor Grinstein, Joseph V. Bonventre

×

Figure 6

Development of fibrotic lesions after injury.

Options: View larger image (or click on image) Download as PowerPoint
Development of fibrotic lesions after injury.
(A) At 3 weeks of age, ani...
(A) At 3 weeks of age, animals with cryoinjury at P1 showed staining for fibrotic lesions as determined by Sirius red and α-SMA, whereas P7 injured animals exhibited more residual indentation and fibrotic lesions at the injury site. Injury with contralateral nephrectomy resulted in healing without fibrosis if injury was carried out on P1 whereas despite nephrectomy fibrosis was present 3 weeks after injury on P7. Original magnification, ×3. (B) Long-term (12 week) follow-up of kidneys subjected to cryoinjury shows indentation and minimal fibrosis at the site of injury in P1-injured animals, with a similar picture in animals with cryoinjury subjected to contralateral nephrectomy. P7-injured animals with cryoinjury had more indentation with fibrotic tissue, as determined by trichrome staining, and this increase was mitigated if there had been contralateral nephrectomy. n = 7 animals per group. Scale bar: 1.0 mm. SMA, smooth muscle actin.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts